Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy

Fig. 7

In vivo chemotherapy efficacy of different formulations in mouse bearing SKOV-3 tumor grafts. When the volume of tumors reached about 50 mm3, mice were intravenously injected with cisplatin, Pt@mPDA/MnO2/PDA NPs or Pt@mPDA/MnO2/PDA-ZHer2 NPs (dose of cisplatin = 2 mg/kg) every 2 days. Tumor-bearing mice intravenously injected with the same volume of PBS were used as control group. The tumor volume and body weight were measured every day. On the 14th day after inoculation, all the tumor grafts were removed, weighed and analyzed by TUNEL staining. a SKOV-3 tumor growth curves of different groups after intravenously injection of the formulations. b The images of tumors isolated after treatment for 8 days. c Mean weights of the tumors isolated on day 14. d Body weight changes over the 8 days of the experiments. e TUNEL-stained images of tumor slices excised from each treatment group on day 14. The nuclei of cells were visualized using DAPI (blue)

Back to article page